Reg4 and its downstream transcriptional activator CD44ICD in stage II and III colorectal cancer

Authors

Jared A. Sninsky, University of North Carolina School of Medicine
Kumar S. Bishnupuri, Washington University School of Medicine in St. Louis
Iván González, Washington University School of Medicine in St. Louis
Nikolaos A. Trikalinos, Washington University School of Medicine in St. Louis
Ling Chen, Washington University School of Medicine in St. Louis
Brian K. Dieckgraefe, Washington University School of Medicine in St. Louis

Journal

Oncotarget

Publication Date

2-16-2021

Volume

12

Issue

4

First Page

278

Last Page

291

Document Type

Open Access Publication

DOI

10.18632/oncotarget.27896

Rights and Permissions

Sninsky J. A., Bishnupuri K. S., González I., Trikalinos N. A., Chen L., Dieckgraefe B. K. Reg4 and its downstream transcriptional activator CD44ICD in stage II and III colorectal cancer. Oncotarget. 2021; 12: 278-291. Retrieved from https://www.oncotarget.com/article/27896/text/. © 2021 Sninsky et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Sninsky, Jared A.; Bishnupuri, Kumar S.; González, Iván; Trikalinos, Nikolaos A.; Chen, Ling; and Dieckgraefe, Brian K., "Reg4 and its downstream transcriptional activator CD44ICD in stage II and III colorectal cancer." Oncotarget. 12, 4. 278 - 291. (2021).
https://digitalcommons.wustl.edu/open_access_pubs/10134